Presentation is loading. Please wait.

Presentation is loading. Please wait.

A heart team’s perspective on interventional mitral valve repair: Percutaneous clip implantation as an important adjunct to a surgical mitral valve program.

Published byFlorian Linden Modified over 5 years ago

Similar presentations

Presentation on theme: "A heart team’s perspective on interventional mitral valve repair: Percutaneous clip implantation as an important adjunct to a surgical mitral valve program."— Presentation transcript:

1 A heart team’s perspective on interventional mitral valve repair: Percutaneous clip implantation as an important adjunct to a surgical mitral valve program for treatment of high-risk patients  Hendrik Treede, MD, Johannes Schirmer, MD, Volker Rudolph, MD, Olaf Franzen, MD, Malgorzata Knap, MD, Michael Schluter, PhD, Lenard Conradi, MD, Moritz Seiffert, MD, Dietmar Koschyk, MD, Thomas Meinertz, MD, Stephan Baldus, MD, Hermann Reichenspurner, MD, PhD  The Journal of Thoracic and Cardiovascular Surgery  Volume 143, Issue 1, Pages (January 2012) DOI: /j.jtcvs Copyright © 2012 The American Association for Thoracic Surgery Terms and Conditions

2 Figure 1 Flow-chart on Heart Team decisions in patients with severe MR at the University Heart Center Hamburg. AVR, Aortic valve repair; CABG, coronary artery bypass grafting; LV, left ventricular; MVR, mitral valve repair. The Journal of Thoracic and Cardiovascular Surgery  , 78-84DOI: ( /j.jtcvs ) Copyright © 2012 The American Association for Thoracic Surgery Terms and Conditions

3 Figure 2 MR at baseline, postprocedure, and 12 months after interventional MVR using the MitraClip device (Abbott Vascular, Menlo Park, Calif) (P < .0001, chi-square test). MR, Mitral regurgitation. The Journal of Thoracic and Cardiovascular Surgery  , 78-84DOI: ( /j.jtcvs ) Copyright © 2012 The American Association for Thoracic Surgery Terms and Conditions

4 Figure 3 Acute reduction in MR from baseline to postprocedure after interventional MVR using the MitraClip device. Mean: −1.7 ± 0.8, n = 202. MR, Mitral regurgitation. The Journal of Thoracic and Cardiovascular Surgery  , 78-84DOI: ( /j.jtcvs ) Copyright © 2012 The American Association for Thoracic Surgery Terms and Conditions

5 Figure 4 Change in NYHA functional class from baseline to discharge and during 12 months follow-up after interventional MVR using the MitraClip device (P = .0001, chi-square test). NYHA, New York Heart Association. The Journal of Thoracic and Cardiovascular Surgery  , 78-84DOI: ( /j.jtcvs ) Copyright © 2012 The American Association for Thoracic Surgery Terms and Conditions

6 Figure 5 Cumulative survival after interventional MVR using the MitraClip device (Kaplan–Meier analysis). The Journal of Thoracic and Cardiovascular Surgery  , 78-84DOI: ( /j.jtcvs ) Copyright © 2012 The American Association for Thoracic Surgery Terms and Conditions

7 Figure 6 Clip-related lesions at the anterior and posterior mitral valve leaflets with chordal rupture (arrows). Both valves were repaired successfully. The Journal of Thoracic and Cardiovascular Surgery  , 78-84DOI: ( /j.jtcvs ) Copyright © 2012 The American Association for Thoracic Surgery Terms and Conditions

8 Figure 7 Volume of surgical and percutaneous mitral valve treatment at the University Heart Center Hamburg 2002–2010. The Journal of Thoracic and Cardiovascular Surgery  , 78-84DOI: ( /j.jtcvs ) Copyright © 2012 The American Association for Thoracic Surgery Terms and Conditions

Download ppt "A heart team’s perspective on interventional mitral valve repair: Percutaneous clip implantation as an important adjunct to a surgical mitral valve program."

Similar presentations

Volume 69, Issue 2, Pages (February 2017)

Volume 69, Issue 2, Pages (February 2017)
The “occasional open heart surgeon” revisited

The “occasional open heart surgeon” revisited
Of mice and men and surgical transcatheter aortic valve insertion

Of mice and men and surgical transcatheter aortic valve insertion
A cherry blossom moment in the history of heart valve replacement

A cherry blossom moment in the history of heart valve replacement
Aortic valve replacement in low-flow, low-gradient aortic stenosis: Left ventricular ejection fraction matters  Victor Dayan, MD, PhD, Philippe Pibarot,

Aortic valve replacement in low-flow, low-gradient aortic stenosis: Left ventricular ejection fraction matters  Victor Dayan, MD, PhD, Philippe Pibarot,
Can papillary muscle interventions improve mitral valve repair durability for ischemic mitral regurgitation?  Christos G. Mihos, DO, Orlando Santana,

Can papillary muscle interventions improve mitral valve repair durability for ischemic mitral regurgitation?  Christos G. Mihos, DO, Orlando Santana,
Is individualized mitral valve repair in the future?

Is individualized mitral valve repair in the future?
Technological innovation in cardiothoracic surgery: A pragmatist's approach  Pedro J. del Nido, MD  The Journal of Thoracic and Cardiovascular Surgery 

Technological innovation in cardiothoracic surgery: A pragmatist's approach  Pedro J. del Nido, MD  The Journal of Thoracic and Cardiovascular Surgery 
Long-term results after surgical treatment of paravalvular leak in the aortic and mitral position  Ismail Bouhout, MD, MSc, Amine Mazine, MD, MSc, Aly.

Long-term results after surgical treatment of paravalvular leak in the aortic and mitral position  Ismail Bouhout, MD, MSc, Amine Mazine, MD, MSc, Aly.
Impact of patient–prosthesis mismatch after transcatheter aortic valve-in-valve implantation in degenerated bioprostheses  Moritz Seiffert, MD, Lenard.

Impact of patient–prosthesis mismatch after transcatheter aortic valve-in-valve implantation in degenerated bioprostheses  Moritz Seiffert, MD, Lenard.
The American Association for Thoracic Surgery 2016 Ethics Forum: Cost-effectiveness and the ethics of left ventricular assist device therapy  John W.C.

The American Association for Thoracic Surgery 2016 Ethics Forum: Cost-effectiveness and the ethics of left ventricular assist device therapy  John W.C.
Valve repair improves the outcome of surgery for chronic severe aortic regurgitation: A propensity score analysis  Christophe de Meester, MS, Agnès Pasquet,

Valve repair improves the outcome of surgery for chronic severe aortic regurgitation: A propensity score analysis  Christophe de Meester, MS, Agnès Pasquet,
Puja Gaur, MD, Tsuyoshi Kaneko, MD, Siobhan McGurk, BS, James D

Puja Gaur, MD, Tsuyoshi Kaneko, MD, Siobhan McGurk, BS, James D
Stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: A meta-analysis of comparative studies  Hisato Takagi,

Stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: A meta-analysis of comparative studies  Hisato Takagi,
Prospective randomized comparison of CarboMedics and St

Prospective randomized comparison of CarboMedics and St
POINT: Efficacy of adding mitral valve restrictive annuloplasty to coronary artery bypass grafting in patients with moderate ischemic mitral valve regurgitation:

POINT: Efficacy of adding mitral valve restrictive annuloplasty to coronary artery bypass grafting in patients with moderate ischemic mitral valve regurgitation:
Design, rationale, and initiation of the Surgical Interventions for Moderate Ischemic Mitral Regurgitation Trial: A report from the Cardiothoracic Surgical.

Design, rationale, and initiation of the Surgical Interventions for Moderate Ischemic Mitral Regurgitation Trial: A report from the Cardiothoracic Surgical.
Aortic valve replacement and mitral valve repair as treatment of complications after percutaneous core valve implantation  Chiara Comoglio, MD, Massimo.

Aortic valve replacement and mitral valve repair as treatment of complications after percutaneous core valve implantation  Chiara Comoglio, MD, Massimo.
Juan A. Crestanello, MD, Richard C. Daly, MD 

Juan A. Crestanello, MD, Richard C. Daly, MD 
Centers for Disease Control “increased-risk” organ donor: Not so risky?  Francis D. Pagani, MD, PhD  The Journal of Thoracic and Cardiovascular Surgery 

Centers for Disease Control “increased-risk” organ donor: Not so risky?  Francis D. Pagani, MD, PhD  The Journal of Thoracic and Cardiovascular Surgery 

Similar presentations

Ads by Google